Home / Central Data Catalog / FRESH-83123-EN
central

Type 2 Diabetes: Key Early Symptoms and How Daily Habits Can Help Control It

France, 2027
Reference ID
FReSH-83123-en
Producer(s)
Tohmas;Martin, PI;1, pi;2, pi;3, pi;4, pi;5, pi ;6
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Sep 08, 2026
Last modified
Sep 11, 2026
Page views
7
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Quality standards
  • Access policy
  • Data Access
  • Contacts
  • Metadata production

    • Identification

    Survey ID number

    FReSH-83123-en
    Title

    Type 2 Diabetes: Key Early Symptoms and How Daily Habits Can Help Control It
    Abbreviation or Acronym

    T2D
    Country
    Name Country code
    France fr
    Abstract

    This accessible yet serious health article breaks down the most common early warning signs of Type 2 diabetes—such as unusual fatigue, constant thirst, and blurred vision. It also explains how modern medications (like metformin) work alongside simple lifestyle changes, such as balanced dieting and regular walking, to help manage blood sugar levels and prevent complications.
    Kind of Data

    ['Clinical data','Other']
    Unit of Analysis

    Individus

    Scope

    Topics
    Topic Vocabulary
    Contact with health services for specific surgical interventions cim-11
    Health Devices, Equipment and Supplies cim-11
    Contact with health services for contraception prescription cim-11
    Biological determinants health determinant
    Other health determinant
    Other determinants, details other determinant

    Coverage

    Geographic Coverage

    ['Ile-de-France','Provence - Alpes - Côte d'Azur']
    Universe

    {
    "level_sex_clusion_I": [
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D005260"
    },
    "value": "Female"
    },
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D008297"
    },
    "value": "Male"
    }
    ],
    "level_age_clusion_I": [
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D000328"
    },
    "value": "Adult (25 to 44 years)"
    },
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D008875"
    },
    "value": "Middle Aged (45 to 64 years)"
    },
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D000368"
    },
    "value": "Aged (65 to 79 years)"
    }
    ],
    "level_type_clusion_I": "Patients population",
    "level_type_clusion_other": "",
    "clusion_I": "Inclusion Criteria\r\n",
    "clusion_E": "Inclusion Criteria\r\n"
    }

    Producers and sponsors

    Primary investigators
    Name
    Tohmas;Martin
    PI;1
    pi;2
    pi;3
    pi;4
    pi;5
    pi ;6
    Producers
    Name Role
    ABBOTT FRANCE sponsor
    AGENCE DE L ENVIRONNEMENT ET DE LA MAITRISE DE L ENERGIE (ADEME) sponsor
    AUTORITE DE SURETE NUCLEAIRE ET DE RADIOPROTECTION (ASNR) sponsor
    ARS BRETAGNE sponsor
    ABBOTT FRANCE sponsor
    Funding Agency/Sponsor
    Name
    ABBOTT FRANCE
    ABBVIE
    ABBOTT FRANCE
    ARS ILE-DE-FRANCE
    AG2R AGIRC-ARRCO (UGRR)
    Other Identifications/Acknowledgments
    Name
    team;1
    AGENCE NATIONALE DE LA COHESION DES TERRITOIRES (ANCT)
    team ;2
    AREVA
    team;3
    BRISTOL MYERS SQUIBB PHARMA FRANCE S.A
    team;4
    ASSOCIATION FRANCAISE DES DIABETIQUES (A F D)

    Study authorization

    Agency
    Agency name
    ANSM
    CNIL
    CNIL
    CPP

    Sampling

    Sample frame

    Unit Type

    ['Administrative database (employees, pupils, students, etc.)','Disease and death registry','Other']
    Sampling Procedure

    ['{"concept":{"vocab":"CESSDA","vocabURI":"Other"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Conditions under which the aggregated data are made available
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    2027-07-09 2027-07-09
    Time Method

    Retrospective longitudinal
    Frequency of Data Collection

    Collection frequency *
    Mode of data collection
    • {"concept":{"vocab":"CESSDA","vocabURI":"Other"},"value":"Other"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Primary Outcome
    Type
    secondary evaluation
    Description
    Secondary Outcome(s)

    Quality standards

    Quality standards
    Standard
    ['Standard(s) or nomenclature(s) used1','Standard(s) or nomenclature(s) used2']
    Other quality statement

    ['Quality procedure used']

    Access policy

    Location of Data Collection

    Data location
    Completeness of Study Stored

    Data file completeness

    Data Access

    Access authority
    Name Email
    Thomas;MARTIN med8@impact-dev.tn
    Citation requirements

    Citation requirement
    Deposit requirements

    Reporting requirement
    Availability Status

    {"extLink":{"title":"COAR","uri":"http://purl.org/coar/access_right/c_abf2"},"value":"Open access"}
    Special Permissions
    Indicate if special permissions are required to access a resource Special permissions description
    Yes Link to the data access request tool

    Contacts

    Contacts
    Name Email
    Tohmas;Martin med8@impact-dev.tn
    team;1 team1@mail.com
    team;3 team3@mail.com
    pi;2 pi2@mail.com
    pi;3 pi3@mail.com
    pi;4 pi4@mail.com
    pi;5 pi5@mail.com
    pi ;6 pi6@mail.com
    team ;2 team2@mail.com
    team;4 team4@mail.com

    Metadata production

    DDI Document ID

    FReSH-83123-en
    Producers
    Name
    Tohmas Martin
    Back to Catalog